Humana Inc. director Kurt J. Hilzinger reported changes in his beneficial ownership of Humana common-stock-linked securities for June 30, 2026, in a Form 4 filed July 2, 2026. The filing reflects director compensation and deferred equity activity rather than an open-market purchase or sale of Humana shares. The reported securities are Humana Inc. common stock units tied to director compensation. Hilzinger received annual director fees payable in stock units, which he had elected to defer. Under the deferral arrangement, the stock units will be paid out in Humana common stock on a one-for-one basis when he ends his service as a director. The filing states that this compensation-related transaction is exempt under Rule 16b-3(d)(1), the SEC rule commonly used for issuer-approved equity awards to directors and officers. The disclosure also notes that the reported holdings include 766 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Humana common stock. These RSUs were granted under Humana’s 2019 Amended & Restated Plan and are described as exempt under Rule 16b-3(d)(1) and Rule 16b-3(d)(3). In addition, Hilzinger reported dividend-related activity: director dividend payments were reinvested into additional stock units on vested and deferred stock units. Like the underlying deferred units, these dividend-equivalent stock units are deferred until Hilzinger’s resignation or departure from the board and will then be settled in Humana common stock on a one-for-one basis. The filing also reports that Hilzinger elected to convert director cash fees into stock units under an election made during a designated enrollment period in the prior year. The filing does not provide visible transaction prices, aggregate post-transaction ownership totals, or table-level transaction codes in the supplied text. The key takeaway is that Hilzinger’s reported ownership change stems from Humana director compensation arrangements—deferred stock units, reinvested dividend equivalents, and cash fees converted into stock units—not from a discretionary market trade.